OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $47,000 | -20.3% | 11,409 | -22.8% | 0.00% | – |
| Q2 2022 | $59,000 | -19.2% | 14,777 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | -13.1% | 14,777 | +22.7% | 0.00% | – |
| Q4 2021 | $84,000 | -30.0% | 12,040 | 0.0% | 0.00% | – |
| Q3 2021 | $120,000 | -29.8% | 12,040 | 0.0% | 0.00% | – |
| Q2 2021 | $171,000 | -13.6% | 12,040 | 0.0% | 0.00% | – |
| Q1 2021 | $198,000 | -20.5% | 12,040 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $249,000 | +196.4% | 12,040 | +9.1% | 0.00% | – |
| Q3 2020 | $84,000 | +1100.0% | 11,040 | +1004.0% | 0.00% | – |
| Q2 2018 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | +75.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |